Format

Send to

Choose Destination
Immunol Allergy Clin North Am. 2019 Feb;39(1):129-140. doi: 10.1016/j.iac.2018.08.009.

Genetic Testing to Diagnose Primary Immunodeficiency Disorders and to Identify Targeted Therapy.

Author information

1
Allergy/Immunology, Perelman School of Medicine at University of Pennsylvania, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA. Electronic address: heimallj@email.chop.edu.

Abstract

Since the first genes associated with primary immunodeficiency were described in the early 1990s, there has been an exponential increase the number of genes found to have pathologic variants in patients with symptoms of primary immunodeficiency. Genetic testing currently used clinically includes chromosomal microarray, Sanger sequencing, and next-generation sequencing techniques, including whole exome testing. With the knowledge of the underlying molecular pathways, biologic therapies have been used for treatment and efforts are underway to broaden the availability of gene therapy.

KEYWORDS:

Chromosomal microarray; Gene editing; Gene therapy; Next-generation sequencing; Primary immunodeficiency; Sanger sequencing; Whole exome sequencing; Whole genome sequencing

PMID:
30466769
DOI:
10.1016/j.iac.2018.08.009

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center